Kolchinsky Peter
SEC CIK 1384859 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | Dir, 10% | 3.29M | $50.71M | — | 4 | 2024-06-27 | 2025-12-11 |
| SION | Sionna Therapeutics, Inc. | Dir, 10% | 660.2K | — | $1.20M | 1 | 2025-11-20 | 2025-11-20 |
| VOR | Vor Biopharma Inc. | Dir, 10% | 1.09M | — | $10.37M | 2 | 2024-12-30 | 2025-10-28 |
| TYRA | Tyra Biosciences, Inc. | Dir, 10% | 9.91M | $11.75M | — | 2 | 2024-10-18 | 2025-06-04 |
| JBIO | Jade Biosciences, Inc. | 10% | 1.29M | — | — | 1 | 2025-04-28 | 2025-04-28 |
| JANX | Janux Therapeutics, Inc. | Dir, 10% | 9.32M | $53.70M | — | 1 | 2024-10-18 | 2024-10-18 |
| ARTV | Artiva Biotherapeutics, Inc. | Dir, 10% | 725.4K | $100.00M | — | 3 | 2024-07-22 | 2024-07-22 |
| BOLD | Boundless Bio, Inc. | 10% | 280.2K | $5.00M | — | 2 | 2024-04-02 | 2024-04-02 |
| PEPG | PepGen Inc. | Dir, 10% | 9.18M | $65.96M | — | 3 | 2022-05-10 | 2024-02-09 |
| WVE | Wave Life Sciences, Inc. | Dir, 10% | 19.20M | $5.00M | — | 1 | 2023-12-11 | 2023-12-11 |
| ELVN | Enliven Therapeutics, Inc. | Former 10% owner | 2.12M | $1.86M | — | 2 | 2022-10-17 | 2023-02-23 |
| FULC | Fulcrum Therapeutics, Inc. | 10% | 9.51M | $607.3K | — | 2 | 2022-12-19 | 2022-12-27 |
| KALA | KALA BIO, Inc. | 10% | 7.04M | — | $362.0K | 1 | 2022-05-26 | 2022-05-26 |
| ANTX | AN2 Therapeutics, Inc. | 10% | 3.25M | $25.00M | — | 2 | 2022-03-29 | 2022-03-29 |
| CTKB | Cytek Biosciences, Inc. | Dir | 507.7K | $50.15M | — | 2 | 2021-07-27 | 2021-07-27 |
Most active insiders at CLYM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thomas Stephen Basil | Dir | — | $2.25M |
| 2 | Kolchinsky Peter | Dir, 10% | $754.7K | — |
| 3 | Brennan Aoife | Pres, CEO, Dir | — | $407.0K |
| 4 | RA Capital Healthcare Fund LP | Dir, 10% | $24.9K | — |
Transactions 29
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DMI | 2025-12-15 | 2025-12-11+ | CLYM | Climb Bio, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $2.40 | +314.6K | 3.29M | +11% | +$754.7K |
| DI | 2025-12-15 | 2025-12-11 | CLYM | Climb Bio, Inc. | Kolchinsky Peter | Dir, 10% | D - Sale to Iss | $0.00 | -20.44M | 3.08M | -87% | $0 |
| MI | 2025-11-24 | 2025-11-20+ | SION | Sionna Therapeutics, Inc. | Kolchinsky Peter | Dir, 10% | S - Sale | $39.61 | -30.3K | 660.2K | -4% | -$1.20M |
| MI | 2025-10-30 | 2025-10-28+ | VOR | Vor Biopharma Inc. | Kolchinsky Peter | Dir, 10% | S - Sale | $25.90 | -400.4K | 1.09M | -27% | -$10.37M |
| MI | 2025-06-06 | 2025-06-04+ | TYRA | Tyra Biosciences, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $9.70 | +1.21M | 9.91M | +14% | +$11.75M |
| I | 2025-04-30 | 2025-04-28 | JBIO | Jade Biosciences, Inc. | Kolchinsky Peter | 10% | J - Other | — | +1.06M | 1.29M | +471% | — |
| DI | 2024-12-30 | 2024-12-30 | VOR | Vor Biopharma Inc. | Kolchinsky Peter | Dir, 10% | A - Grant | — | +16.90M | 37.82M | +81% | — |
| DI | 2024-10-22 | 2024-10-18 | TYRA | Tyra Biosciences, Inc. | Kolchinsky Peter | Dir, 10% | J - Other | — | -1.00M | 7.48M | -12% | — |
| I | 2024-10-22 | 2024-10-18 | JANX | Janux Therapeutics, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $44.75 | +1.20M | 9.32M | +15% | +$53.70M |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Kolchinsky Peter | Dir, 10% | C - Cnv Deriv | — | +1.06M | 725.4K | New | — |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Kolchinsky Peter | Dir, 10% | J - Other | $10.20 | +461.7K | 1.05M | +79% | +$4.71M |
| DMI | 2024-07-24 | 2024-07-22 | ARTV | Artiva Biotherapeutics, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $12.00 | +8.33M | 826.8K | New | +$100.00M |
| MI | 2024-07-01 | 2024-06-27 | CLYM | Climb Bio, Inc. | Kolchinsky Peter | Dir, 10% | A - Grant | — | +5.26M | 11.57M | +83% | — |
| MI | 2024-07-01 | 2024-06-27 | CLYM | Climb Bio, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $3.84 | +13.01M | 2.87M | New | +$49.95M |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | Kolchinsky Peter | 10% | C - Cnv Deriv | — | +1.87M | 280.2K | New | — |
| DMI | 2024-04-04 | 2024-04-02 | BOLD | Boundless Bio, Inc. | Kolchinsky Peter | 10% | P - Purchase | $16.00 | +312.5K | 1.88M | +20% | +$5.00M |
| I | 2024-02-13 | 2024-02-09 | PEPG | PepGen Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $10.64 | +2.56M | 9.18M | +39% | +$27.21M |
| I | 2023-12-13 | 2023-12-11 | WVE | Wave Life Sciences, Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $5.00 | +1.00M | 19.20M | +5% | +$5.00M |
| I | 2023-02-27 | 2023-02-23 | ELVN | Enliven Therapeutics, Inc. | Kolchinsky Peter | Former 10% owner | A - Grant | — | +1.15M | 2.12M | +119% | — |
| I | 2022-12-29 | 2022-12-27 | FULC | Fulcrum Therapeutics, Inc. | Kolchinsky Peter | 10% | P - Purchase | $5.99 | +4,089 | 9.51M | +0.0% | +$24.5K |
| I | 2022-12-21 | 2022-12-19 | FULC | Fulcrum Therapeutics, Inc. | Kolchinsky Peter | 10% | P - Purchase | $5.90 | +98.8K | 9.50M | +1% | +$582.8K |
| MI | 2022-10-19 | 2022-10-17+ | ELVN | Enliven Therapeutics, Inc. | Kolchinsky Peter | 10% | P - Purchase | $3.68 | +506.2K | 2.77M | +22% | +$1.86M |
| I | 2022-05-26 | 2022-05-26 | KALA | KALA BIO, Inc. | Kolchinsky Peter | 10% | S - Sale | $0.36 | -1.01M | 7.04M | -13% | -$362.0K |
| DMI | 2022-05-12 | 2022-05-10 | PEPG | PepGen Inc. | Kolchinsky Peter | Dir, 10% | P - Purchase | $12.00 | +3.23M | 1.30M | New | +$38.75M |
| DMI | 2022-05-12 | 2022-05-10 | PEPG | PepGen Inc. | Kolchinsky Peter | Dir, 10% | C - Cnv Deriv | — | +4.90M | 3.64M | New | — |
| DMI | 2022-03-31 | 2022-03-29 | ANTX | AN2 Therapeutics, Inc. | Kolchinsky Peter | 10% | P - Purchase | $15.00 | +1.67M | 3.25M | +105% | +$25.00M |
| DMI | 2022-03-31 | 2022-03-29 | ANTX | AN2 Therapeutics, Inc. | Kolchinsky Peter | 10% | C - Cnv Deriv | — | +2.00M | 1.70M | New | — |
| DMI | 2021-07-29 | 2021-07-27 | CTKB | Cytek Biosciences, Inc. | Kolchinsky Peter | Dir | C - Cnv Deriv | — | +6.66M | 507.7K | New | — |
| DMI | 2021-07-29 | 2021-07-27 | CTKB | Cytek Biosciences, Inc. | Kolchinsky Peter | Dir | P - Purchase | $17.00 | +2.95M | 1.19M | New | +$50.15M |
Purchase Sale Sale after option exercise All abbreviations